Featured
Health Topics
- Analytical, Diagnostic and Therapeutic Techniques and Equipment27 See more
-
Chemicals and Drugs218
See more
- Amino Acids, Peptides, and Proteins 58
- Biological Factors 16
- Biomedical and Dental Materials 1
- Carbohydrates 10
- Chemical Actions and Uses 39
- Complex Mixtures 20
- Enzymes and Coenzymes 4
- Heterocyclic Compounds 67
- Hormones, Hormone Substitutes, and Hormone Antagonists 18
- Inorganic Chemicals 33
- Lipids 4
- Macromolecular Substances 1
- Nucleic Acids, Nucleotides, and Nucleosides 5
- Organic Chemicals 104
- Pharmaceutical Preparations 6
- Polycyclic Compounds 33
-
Diseases436
See more
- Bacterial Infections and Mycoses 35
- Cardiovascular Diseases 45
- Chemically-Induced Disorders 28
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities 54
- Digestive System Diseases 37
- Endocrine System Diseases 46
- Eye Diseases 7
- Female Urogenital Diseases and Pregnancy Complications 36
- Hemic and Lymphatic Diseases 38
- Immune System Diseases 61
- Male Urogenital Diseases 34
- Musculoskeletal Diseases 15
- Neoplasms 83
- Nervous System Diseases 69
- Nutritional and Metabolic Diseases 80
- Otorhinolaryngologic Diseases 11
- Parasitic Diseases 10
- Pathological Conditions, Signs and Symptoms 150
- Respiratory Tract Diseases 19
- Skin and Connective Tissue Diseases 18
- Stomatognathic Diseases 8
- Virus Diseases 40
- Wounds and Injuries 8
- Health Care2 See more
- Phenomena and Processes36 See more
- Psychiatry and Psychology71 See more
- Technology, Industry, Agriculture6 See more
Search Clinical Trials
Completed
Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H (External Link)
This is a two arm study in which outcomes will be assessed independently in recipients of HLA matched sibling transplants and recipients of unrelated or mismatched family donor transplants, although …
Baylor Role:
Lead Sponsor
Completed
Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants With Brain Tumors (External Link)
All children in the study will receive Regimen 1 chemotherapy. Children whose tumor is limited to one area at the beginning of the study will go on to have radiation …
Baylor Role:
Lead Sponsor
Completed
T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts (External Link)
To participate in this study, the subject will need to have a central line (a thin plastic catheter or tube that is placed during surgery into one of the large …
Baylor Role:
Lead Sponsor
Completed
Treating Severe Chronic Epstein-Barr Virus (EBV) Infection With EBV Specific Cytotoxic T Lymphocytes (CTLs) (External Link)
Ten to sixty ml (2-12 teaspoons) of blood will be collected from the patient which we use to grow the T cells. These T cells are then stimulated with EBV …
Baylor Role:
Lead Sponsor
Completed
Neuroblastoma Vaccine for Treatment of High-Risk Neuroblastoma After Chemotherapy (External Link)
Tumor cells from subjects with high-risk neuroblastoma will be obtained at the time of presentation and initial diagnosis, during routine surveillance of bone marrow disease status, or at the time …
Completed
Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion Syndromes (External Link)
PROTOCOL OUTLINE: Patients undergo clinical, cytogenetic, and molecular studies. These include radiographic, neurologic, developmental, and 24 hour sleep studies, ophthalmologic, otolaryngologic, speech and language, and audiologic exams, echocardiogram, and renal …
Baylor Role:
Collaborator
Completed
Stem Cell Transplant to Treat Patients With Systemic Sclerosis (External Link)
Before the transplant the research participant will receive daily G-CSF (Neupogen) for 5-6 days. This medication will help to stimulate the production of white blood cells (WBC) that will be …
Baylor Role:
Lead Sponsor
Completed
Treating High Risk Leukemia With CD40 Ligand & IL-2 Gene Modified Tumor Vaccine (External Link)
Before starting in the treatment part of this study, leukemia cells and skin fibroblasts will be collected from the patient - called "procurement" - to allow us to make the …
Baylor Role:
Lead Sponsor
Completed
High Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple Sclerosis (External Link)
To participate in this study, patients will need to have a central line (a thin plastic catheter or tube that is placed during surgery into one of the large veins …
Baylor Role:
Lead Sponsor
Completed
Control of Epidemic Influenza Through a School-based Influenza Vaccination Program (External Link)
This study was conducted in three phases. The first phase spanned from 1998-2003 (PubMed ID:14706961; PubMed ID: 12915495) and the second phase spanned from 2003-2007 (PubMedID: 18401289; PubMed ID: 17698577). …
Baylor Role:
Lead Sponsor